Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study-Reference-Cited by-同舟云学术

Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study

Published:2023-10-10 Issue:1 Volume:103 Page:163-174
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Wei Yu-Ce,Liu Wei-Xin,Qi Fei,Zhang Chang-Gong,Zheng Bao-Min,Xie Yan,Chen Bo,Zhang Di,Liu Wei-Ping,Fang Hui,Chai Yue,Qi Shu-Nan,Li Ye-Xiong,Wang Wei-Hu,Song Yu-Qin,Zhu Jun,Dong Mei^ORCID

Funder

Chinese Geriatric Oncology Society Scientific Research Fund

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05455-4.pdf

Reference36 articles.

1. Liu QF, Wang WH, Wang SL et al (2014) Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma. Int J Radiat Oncol 88:806–813. https://doi.org/10.1016/j.ijrobp.2013.12.005

2. Yamaguchi M, Suzuki R, Miyazaki K et al (2019) Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin. Ann Hematol 98:1647–1655. https://doi.org/10.1007/s00277-019-03689-9

3. Qi S, Yang Y, Zhang Y et al (2020) Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK /T-cell lymphoma in the modern chemotherapy era: a China Lymphoma Collaborative Group study. Am J Hematol 95:1047–1056. https://doi.org/10.1002/ajh.25878

4. Au W, Weisenburger DD, Intragumtornchai T et al (2009) Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 113:3931–3937. https://doi.org/10.1182/blood-2008-10-185256

5. Fox CP, Civallero M, Ko Y-H et al (2020) Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project. Lancet Haematol 7:e284–e294. https://doi.org/10.1016/S2352-3026(19)30283-2